Clinical Trial Update: MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 study evaluating MK0752 in combination with gemcitabine hydrochloride for unresectable stage III/IV pancreatic cancer has completed enrollment; this doc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• MK0752

Snippet

Sponsor: Cancer Research UK | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED